Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (72)

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)

    Virchows Archiv, Vol. 482, Núm. 3, pp. 615-623

  2. Should we suspect primary aldosteronism in patients with hypokalaemic rhabdomyolysis? A systematic review

    Frontiers in Endocrinology, Vol. 14

2022

  1. Adrenal Medullary Hyperplasia: An Under the Radar Cause of Endocrine Hypertension

    American Journal of the Medical Sciences, Vol. 363, Núm. 1, pp. 64-68

  2. Single-cell mtDNA heteroplasmy in colorectal cancer

    Genomics, Vol. 114, Núm. 2

  3. Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys

    Frontiers in Endocrinology, Vol. 13

2021

  1. Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates

    Endocrine Pathology, Vol. 32, Núm. 1, pp. 77-101

  2. PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study

    Oncology Letters, Vol. 22, Núm. 1

  3. The Authors Reply PMC and PMT: Real Medicine and Not Just Biology

    American Journal of Surgical Pathology

2020

  1. A novel nanoproteomic approach for the identification of molecular targets associated with thyroid tumors

    Nanomaterials, Vol. 10, Núm. 12, pp. 1-20

  2. Evaluation of 177Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors

    World Journal of Gastroenterology, Vol. 26, Núm. 13, pp. 1513-1524

  3. GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

    Frontiers in Endocrinology, Vol. 11

  4. Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers

    Endocrine Pathology, Vol. 31, Núm. 3, pp. 197-217

  5. Sequential colocalization of ERa, PR, and AR hormone receptors using confocal microscopy enables new insights into normal breast and prostate tissue and cancers

    Cancers, Vol. 12, Núm. 12, pp. 1-22

  6. Thyroid papillary microtumor: Validation of the (updated) porto proposal assessing sex hormone receptor expression and mutational BRAF gene status

    American Journal of Surgical Pathology, Vol. 44, Núm. 9, pp. 1161-1172

2019

  1. Early colorectal cancers provide new evidence for a lynch syndrome-to-CMMRD phenotypic continuum

    Cancers, Vol. 11, Núm. 8

  2. Novel TMEM127 Variant Associated to Bilateral Phaeochromocytoma with an Uncommon Clinical Presentation

    Case Reports in Endocrinology, Vol. 2019

  3. Rapid evolution and biogeographic spread in a colorectal cancer

    Nature Communications, Vol. 10, Núm. 1